Heart Test Laboratories Inc. Common Stock (HSCS) Stock Analysis

Heart Test Laboratories Inc. Common Stock (HSCS) is a publicly traded company in the HEALTHCARE sector. It trades at $2.07, carries a market capitalization of $6.46M. This page summarizes the public market data, fundamentals, and frequently asked questions for HSCS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

About Heart Test Laboratories Inc. Common Stock

Heart Test Laboratories, Inc. (HSCS) is a forward-thinking medical technology company headquartered in Southlake, Texas, dedicated to the development and commercialization of innovative cardiovascular diagnostic devices. By focusing on advanced technologies that enhance the accuracy and efficiency of heart health assessments, HSCS addresses a crucial demand in the expanding cardiovascular care market. The company's commitment to research-driven solutions positions it as a potential leader in ...

GNG Research Analysis

GNG Research scores Heart Test Laboratories Inc. Common Stock (HSCS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HSCS.

Frequently Asked Questions

Does HSCS pay dividends?

Heart Test Laboratories Inc. Common Stock (HSCS) does not currently pay a regular dividend.

What is HSCS's market cap?

Heart Test Laboratories Inc. Common Stock (HSCS) has a market capitalization of $6.46M with a current stock price of $2.07.